Currently, there is no official direct link established between GLP-1 receptor agonists and clinically significant magnesium depletion
Bottom line Mounjaro (tirzepatide) is a GLP-1 and GIP dual receptor agonist containing the same active ingredient as Zepbound, a weight loss drug made by the same manufacturer, Novo Nordisk
Weight Loss Medications in Addiction Recovery Emerging research suggests that some weight loss medications may benefit individuals with co-occurring substance use disorders (SUDs)
Knocking out KRAS (the most common gene mutation in 95% PDA patients) in cancer cells even made insulin lose the ability to promote cancer cell viability, and insulin even turned to induced tumor cell dormancy in vitro experiments (Rajbhandari et al., 2017)
Has the product been evaluated for quality, purity, sterility, and safety